Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNeuropharmacology

Inhibition of Excitatory Synaptic Transmission in Hippocampal Neurons by Levetiracetam Involves Zn2+-Dependent GABA Type A Receptor–Mediated Presynaptic Modulation

Masahito Wakita, Naoki Kotani, Kyuya Kogure and Norio Akaike
Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 246-259; DOI: https://doi.org/10.1124/jpet.113.208751
Masahito Wakita
Research Division for Clinical Pharmacology, Medical Corporation, Jyuryokai, Kumamoto Kinoh Hospital, Kumamoto, Japan (M.W., N.A.); Research Division for Life Science, Kumamoto Health Science University, Kumamoto, Japan (M.W., N.A.); Research Division of Neurophysiology, Kitamoto Hospital, Koshigaya, Japan (N.K., N.A); and Kogure Medical Clinic, Chouseikai Medical Corporation, Fukaya City, Saitama, Japan (K.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoki Kotani
Research Division for Clinical Pharmacology, Medical Corporation, Jyuryokai, Kumamoto Kinoh Hospital, Kumamoto, Japan (M.W., N.A.); Research Division for Life Science, Kumamoto Health Science University, Kumamoto, Japan (M.W., N.A.); Research Division of Neurophysiology, Kitamoto Hospital, Koshigaya, Japan (N.K., N.A); and Kogure Medical Clinic, Chouseikai Medical Corporation, Fukaya City, Saitama, Japan (K.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyuya Kogure
Research Division for Clinical Pharmacology, Medical Corporation, Jyuryokai, Kumamoto Kinoh Hospital, Kumamoto, Japan (M.W., N.A.); Research Division for Life Science, Kumamoto Health Science University, Kumamoto, Japan (M.W., N.A.); Research Division of Neurophysiology, Kitamoto Hospital, Koshigaya, Japan (N.K., N.A); and Kogure Medical Clinic, Chouseikai Medical Corporation, Fukaya City, Saitama, Japan (K.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norio Akaike
Research Division for Clinical Pharmacology, Medical Corporation, Jyuryokai, Kumamoto Kinoh Hospital, Kumamoto, Japan (M.W., N.A.); Research Division for Life Science, Kumamoto Health Science University, Kumamoto, Japan (M.W., N.A.); Research Division of Neurophysiology, Kitamoto Hospital, Koshigaya, Japan (N.K., N.A); and Kogure Medical Clinic, Chouseikai Medical Corporation, Fukaya City, Saitama, Japan (K.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 348 no. 2 246-259
DOI 
https://doi.org/10.1124/jpet.113.208751
PubMed 
24259680

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received August 13, 2013
  • Accepted November 19, 2013
  • Published online January 2, 2014.

Article Versions

  • Earlier version (November 20, 2013 - 12:47).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Masahito Wakita,
  2. Naoki Kotani,
  3. Kyuya Kogure, and
  4. Norio Akaike
  1. Research Division for Clinical Pharmacology, Medical Corporation, Jyuryokai, Kumamoto Kinoh Hospital, Kumamoto, Japan (M.W., N.A.); Research Division for Life Science, Kumamoto Health Science University, Kumamoto, Japan (M.W., N.A.); Research Division of Neurophysiology, Kitamoto Hospital, Koshigaya, Japan (N.K., N.A); and Kogure Medical Clinic, Chouseikai Medical Corporation, Fukaya City, Saitama, Japan (K.K.)
  1. Address correspondence to:
    Dr. Norio Akaike, Research Division for Life Sciences, Kumamoto Health Science University, 325 Izumi-machi, Kitaku, Kumamoto, 861–5598, Japan. E-mail: akaike{at}kumamoto-hsu.ac.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2013 to May 2023

AbstractFullPdf
Nov 201396063
Dec 2013930110
Jan 20144832249
Feb 20141251320
Mar 20141022432
Apr 2014601627
May 2014422323
Jun 201444915
Jul 2014471318
Aug 20142764
Sep 20143895
Oct 20143466
Nov 2014261011
Dec 20141625
Jan 2015352012
Feb 2015251520
Mar 2015241511
Apr 201592212
May 2015112011
Jun 2015202217
Jul 2015241920
Aug 201518197
Sep 2015292019
Oct 20158215
Nov 2015231011
Dec 20151398
Jan 201616227
Feb 2016211212
Mar 2016143028
Apr 2016121925
May 201661416
Jun 2016321427
Jul 2016201532
Aug 2016251020
Sep 2016121721
Oct 2016103319
Nov 2016125133
Dec 201633219
Jan 20171184
Feb 20171182
Mar 20172315
Apr 20172191
May 20171207
Jun 201742613
Jul 20172238
Aug 201793034
Sep 2017220720
Oct 2017219712
Nov 20173138
Dec 201711012
Jan 201811313
Feb 201801813
Mar 201831612
Apr 2018022014
May 201819720
Jun 201802718
Jul 20185777
Aug 201832513
Sep 201802616
Oct 201805726
Nov 201824521
Dec 201804721
Jan 201948517
Feb 201947217
Mar 201923212
Apr 20198112
May 2019832
Jun 20191026
Jul 20191017
Aug 20192333
Sep 20193231
Oct 20192926
Nov 20192824
Dec 2019364
Jan 2020720
Feb 20202353
Mar 202027103
Apr 20201922
May 2020938
Jun 20201020
Jul 20201745
Aug 2020801
Sep 20201211
Oct 2020711
Nov 20201301
Dec 20201512
Jan 20211303
Feb 20211524
Mar 20213065
Apr 20211222
May 2021921
Jun 2021910
Jul 20211412
Aug 2021934
Sep 20211511
Oct 2021910
Nov 20213373
Dec 20211852
Jan 20221217
Feb 2022833
Mar 202215105
Apr 20223559
May 20222532
Jun 20222211
Jul 20222311
Aug 20221212
Sep 20221524
Oct 2022721
Nov 20221421
Dec 20221302
Jan 20232433
Feb 20232032
Mar 20232233
Apr 20233343
May 20231923

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 348 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 348, Issue 2
1 Feb 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Excitatory Synaptic Transmission in Hippocampal Neurons by Levetiracetam Involves Zn2+-Dependent GABA Type A Receptor–Mediated Presynaptic Modulation
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNeuropharmacology

Levetiracetam and Glutamatergic Transmission

Masahito Wakita, Naoki Kotani, Kyuya Kogure and Norio Akaike
Journal of Pharmacology and Experimental Therapeutics February 1, 2014, 348 (2) 246-259; DOI: https://doi.org/10.1124/jpet.113.208751

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleNeuropharmacology

Levetiracetam and Glutamatergic Transmission

Masahito Wakita, Naoki Kotani, Kyuya Kogure and Norio Akaike
Journal of Pharmacology and Experimental Therapeutics February 1, 2014, 348 (2) 246-259; DOI: https://doi.org/10.1124/jpet.113.208751
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • VTA Muscarinic M5 Receptors and Effort-Choice Behavior
  • Substituted Tryptamine Activity at 5-HT Receptors and SERT
  • KRM-II-81 Analogs
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics